Cargando…
Correction: Exploiting MEK Inhibitor-Mediated Activation of ERα for Therapeutic Intervention in ER-Positive Ovarian Carcinoma
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4788279/ https://www.ncbi.nlm.nih.gov/pubmed/26967738 http://dx.doi.org/10.1371/journal.pone.0151750 |
| _version_ | 1782420710447120384 |
|---|---|
| author | Hou, June Y. Rodriguez-Gabin, Alicia Samaraweera, Leleesha Hazan, Rachel Goldberg, Gary L. Horwitz, Susan Band McDaid, Hayley M. |
| author_facet | Hou, June Y. Rodriguez-Gabin, Alicia Samaraweera, Leleesha Hazan, Rachel Goldberg, Gary L. Horwitz, Susan Band McDaid, Hayley M. |
| author_sort | Hou, June Y. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4788279 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | Public Library of Science |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-47882792016-03-23 Correction: Exploiting MEK Inhibitor-Mediated Activation of ERα for Therapeutic Intervention in ER-Positive Ovarian Carcinoma Hou, June Y. Rodriguez-Gabin, Alicia Samaraweera, Leleesha Hazan, Rachel Goldberg, Gary L. Horwitz, Susan Band McDaid, Hayley M. PLoS One Correction Public Library of Science 2016-03-11 /pmc/articles/PMC4788279/ /pubmed/26967738 http://dx.doi.org/10.1371/journal.pone.0151750 Text en © 2016 Hou et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Correction Hou, June Y. Rodriguez-Gabin, Alicia Samaraweera, Leleesha Hazan, Rachel Goldberg, Gary L. Horwitz, Susan Band McDaid, Hayley M. Correction: Exploiting MEK Inhibitor-Mediated Activation of ERα for Therapeutic Intervention in ER-Positive Ovarian Carcinoma |
| title | Correction: Exploiting MEK Inhibitor-Mediated Activation of ERα for Therapeutic Intervention in ER-Positive Ovarian Carcinoma |
| title_full | Correction: Exploiting MEK Inhibitor-Mediated Activation of ERα for Therapeutic Intervention in ER-Positive Ovarian Carcinoma |
| title_fullStr | Correction: Exploiting MEK Inhibitor-Mediated Activation of ERα for Therapeutic Intervention in ER-Positive Ovarian Carcinoma |
| title_full_unstemmed | Correction: Exploiting MEK Inhibitor-Mediated Activation of ERα for Therapeutic Intervention in ER-Positive Ovarian Carcinoma |
| title_short | Correction: Exploiting MEK Inhibitor-Mediated Activation of ERα for Therapeutic Intervention in ER-Positive Ovarian Carcinoma |
| title_sort | correction: exploiting mek inhibitor-mediated activation of erα for therapeutic intervention in er-positive ovarian carcinoma |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4788279/ https://www.ncbi.nlm.nih.gov/pubmed/26967738 http://dx.doi.org/10.1371/journal.pone.0151750 |
| work_keys_str_mv | AT houjuney correctionexploitingmekinhibitormediatedactivationoferafortherapeuticinterventioninerpositiveovariancarcinoma AT rodriguezgabinalicia correctionexploitingmekinhibitormediatedactivationoferafortherapeuticinterventioninerpositiveovariancarcinoma AT samaraweeraleleesha correctionexploitingmekinhibitormediatedactivationoferafortherapeuticinterventioninerpositiveovariancarcinoma AT hazanrachel correctionexploitingmekinhibitormediatedactivationoferafortherapeuticinterventioninerpositiveovariancarcinoma AT goldberggaryl correctionexploitingmekinhibitormediatedactivationoferafortherapeuticinterventioninerpositiveovariancarcinoma AT horwitzsusanband correctionexploitingmekinhibitormediatedactivationoferafortherapeuticinterventioninerpositiveovariancarcinoma AT mcdaidhayleym correctionexploitingmekinhibitormediatedactivationoferafortherapeuticinterventioninerpositiveovariancarcinoma |